Roberts; Brian K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Roberts; Brian K..The latest application filed is for "methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent".

Company Profile

1.13.17

Roberts; Brian K. - Palo Alto CA
Roberts; Brian K. - Hayward CA
Roberts; Brian K. - Hillsboro OR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Grant 10,137,112 - Roberts , et al. November 27, 2	2018-11-27
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1- -yl}-pyrimidine Grant 10,098,843 - McWherter , et al. October 16, 2	2018-10-16
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent App 20180214420 - Roberts; Brian K. ; et al.	2018-08-02
Methods for Treating Gout Flares App 20180055803 - Lavan; Brian Edward ; et al.	2018-03-01
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Grant 9,801,860 - Roberts , et al. October 31, 2	2017-10-31
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent App 20160271111 - Roberts; Brian K. ; et al.	2016-09-22
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Grant 9,439,891 - Roberts , et al. September 13, 2	2016-09-13
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Grant 9,433,612 - Roberts , et al. September 6, 2	2016-09-06
Compositions Of 5-ethyl-2--pyrimidine App 20160213618 - McWherter; Charles A. ; et al.	2016-07-28
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent App 20160051520 - Roberts; Brian K. ; et al.	2016-02-25
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1- -yl}-pyrimidine Grant 9,241,924 - McWherter , et al. January 26, 2	2016-01-26
Methods for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halofenic Acid and a Second Urate-Lowering Agent App 20150258053 - Roberts; Brian K. ; et al.	2015-09-17
Methods for treating gout flares Grant 9,060,987 - Lavan , et al. June 23, 2	2015-06-23
Methods for treating hyperuricemia in patients with gout using halofenate or halogenic acid and a second urate-lowering agent Grant 9,023,856 - Roberts , et al. May 5, 2	2015-05-05
Methods for Treating Gout Flares App 20140128438 - Lavan; Brian Edward ; et al.	2014-05-08
Methods for Treating Gout Flares App 20140128439 - Lavan; Brian Edward ; et al.	2014-05-08
Pattern implementation technique Grant 8,661,405 - Stevenson , et al. February 25, 2	2014-02-25
Methods for Treating Gout in Patients Subpopulations App 20130302305 - Saha; Gopal Chandra ; et al.	2013-11-14
Method for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halofenic Acid and an Anti-Inflammatory Agent App 20130274331 - Saha; Gopal Chandra ; et al.	2013-10-17
Methods for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halogenic Acid and A Second Urate-Lowering Agent App 20130172368 - Roberts; Brian K. ; et al.	2013-07-04
Pattern Implementation Technique App 20120023477 - Stevenson; David R. ; et al.	2012-01-26
Compositions Of 5-ethyl-2--pyrimidine App 20110318418 - McWherter; Charles A. ; et al.	2011-12-29
Pattern implementation technique Grant 8,056,048 - Stevenson , et al. November 8, 2	2011-11-08
Pattern implementation technique App 20070043992 - Stevenson; David R. ; et al.	2007-02-22

Company Registrations

SEC

0001259094

ROBERTS BRIAN K

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.